Taline V Khroyan1,2, Donna M Platt3, James K Rowlett3, Roger D Spealman3. 1. SRI International, Center for Health Sciences, 333 Ravenswood Ave, Menlo Park, CA 94025, USA. Taline.Khroyan@sri.com. 2. New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA. Taline.Khroyan@sri.com. 3. New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA.
Abstract
RATIONALE: Dopamine D(1) receptor agonists and antagonists attenuate reinstatement of cocaine seeking in a non-human primate model of relapse. The mechanisms by which these different classes of D(1) receptor drugs produce these similar effects on cocaine seeking are unknown. OBJECTIVES: This study investigated how D(1) receptor agonists and antagonists alter the shape and position of the dose-response function for reinstatement of drug seeking induced by a cocaine prime accompanied by restoration of the cocaine-paired stimulus. METHODS: Squirrel monkeys were given extensive histories of cocaine self-administration under a second-order fixed-interval, fixed-ratio schedule of i.v. drug injection. Drug seeking was then extinguished by replacing cocaine with vehicle and eliminating the cocaine-paired stimulus. In subsequent test sessions, in which the cocaine-paired stimulus was re-introduced, priming injections of cocaine alone or combined with the different D(1) receptor high- and low-efficacy agonists and antagonists (SKF 82958, SKF 81297, SKF 83959, ecopipam; n=3-4 per drug condition) were tested for their ability to reinstate extinguished cocaine seeking. RESULTS: Cocaine priming accompanied by the restoration of the cocaine-paired stimulus induced a dose-dependent reinstatement of drug seeking. When combined with cocaine, all D(1) receptor agonists and antagonists produced rightward and downward shifts in the cocaine dose-response function. However, combined pretreatment of SKF81297 (agonist) and ecopipam (antagonist) inhibited cocaine seeking less than either drug individually. CONCLUSIONS: These findings suggest that D(1) receptor high- and low-efficacy agonists as well as antagonists attenuate reinstatement of cocaine seeking in part via pharmacologically opposing actions at a common population of D(1) receptors.
RATIONALE: Dopamine D(1) receptor agonists and antagonists attenuate reinstatement of cocaine seeking in a non-human primate model of relapse. The mechanisms by which these different classes of D(1) receptor drugs produce these similar effects on cocaine seeking are unknown. OBJECTIVES: This study investigated how D(1) receptor agonists and antagonists alter the shape and position of the dose-response function for reinstatement of drug seeking induced by a cocaine prime accompanied by restoration of the cocaine-paired stimulus. METHODS: Squirrel monkeys were given extensive histories of cocaine self-administration under a second-order fixed-interval, fixed-ratio schedule of i.v. drug injection. Drug seeking was then extinguished by replacing cocaine with vehicle and eliminating the cocaine-paired stimulus. In subsequent test sessions, in which the cocaine-paired stimulus was re-introduced, priming injections of cocaine alone or combined with the different D(1) receptor high- and low-efficacy agonists and antagonists (SKF 82958, SKF 81297, SKF 83959, ecopipam; n=3-4 per drug condition) were tested for their ability to reinstate extinguished cocaine seeking. RESULTS:Cocaine priming accompanied by the restoration of the cocaine-paired stimulus induced a dose-dependent reinstatement of drug seeking. When combined with cocaine, all D(1) receptor agonists and antagonists produced rightward and downward shifts in the cocaine dose-response function. However, combined pretreatment of SKF81297 (agonist) and ecopipam (antagonist) inhibited cocaine seeking less than either drug individually. CONCLUSIONS: These findings suggest that D(1) receptor high- and low-efficacy agonists as well as antagonists attenuate reinstatement of cocaine seeking in part via pharmacologically opposing actions at a common population of D(1) receptors.
Authors: F Weiss; R Martin-Fardon; R Ciccocioppo; T M Kerr; D L Smith; O Ben-Shahar Journal: Neuropsychopharmacology Date: 2001-09 Impact factor: 7.853
Authors: Andrea T Alleweireldt; Suzanne M Weber; Kenneth F Kirschner; Breanna L Bullock; Janet L Neisewander Journal: Psychopharmacology (Berl) Date: 2001-10-12 Impact factor: 4.530
Authors: Yazmin Figueroa-Guzman; Christopher Mueller; Oliver Vranjkovic; Samantha Wisniewski; Zheng Yang; Shi-Jiang Li; Colin Bohr; Evan N Graf; David A Baker; John R Mantsch Journal: Drug Alcohol Depend Date: 2010-12-31 Impact factor: 4.492
Authors: Kenneth J Thiel; Jennifer M Wenzel; Nathan S Pentkowski; Rebecca J Hobbs; Andrea T Alleweireldt; Janet L Neisewander Journal: Behav Brain Res Date: 2010-06-19 Impact factor: 3.332
Authors: Diana Martinez; Mark Slifstein; Rajesh Narendran; Richard W Foltin; Allegra Broft; Dah-Ren Hwang; Audrey Perez; Anissa Abi-Dargham; Marian W Fischman; Herbert D Kleber; Marc Laruelle Journal: Neuropsychopharmacology Date: 2009-01-28 Impact factor: 7.853